About Enhancer
| Enhancer ID: | E_00696 |
| Species: | Homo sapiens |
| Position : | chr9:96928325-96929213   |
| Year: | 2020 |
| Title: | Noncoding Variants Connect Enhancer Dysregulation with Nuclear Receptor Signaling in Hematopoietic Malignancies. |
| Genome Build: | hg19 |
| Enhancer Type: | Enhancer |
| Condition: | Disease |
| Disease Name: | hematologic malignancy |
| PMID: | 32188707 |
| MONDO: | MONDO:0021447 |
| Tissue: | blood |
| Tissue Ontology ID: | UBERON:0000178 |
| Cell Source: | K-562 |
| CVCL ID: | CVCL_0004 |
| Experiment Type: | Enhancer activity assay; Functional perturbation assay |
| High Throughput Method: | enCRISPRa screen; enCRISPRi screen; targeted resequencing |
| Low Throughput Method: | CRISPR activation; CRISPR interference |
About Target Gene
| Target gene : | MIRLET7A1 |
About TF
| TF name : | NA |
About Regulatory State
| Regulatory State : | Active |
Upstream Pathway Annotation of TF
| GeneName | Pathway Name | Source | Gene Number |
|---|
Enhancer Associated Network
Expression of Target Genes for the Enhancer